home / stock / kne:cc / kne:cc news

KNE:CC News and Press, Kane Biotech Inc. From 11/28/23

Stock Information
Company Name: Kane Biotech Inc.
Stock Symbol: KNE:CC
Market: TSXVC
Website: kanebiotech.com
Menu
KNE:CC KNE:CC Quote KNE:CC Short KNE:CC News KNE:CC Articles KNE:CC Message Board
Get KNE:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
KNE:CC - Kane Biotech Announces Improved Third Quarter 2023 Financial Results

WINNIPEG, Manitoba, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announced its third quarter 2023 financial results. Third Quarter Financial Highlights: Revenue from product and ser...
KNE:CC - Expected Canadian Company Earnings on Tuesday, November 28th, 2023

MacDonald Mines Exploration Ltd. (BMK:CA) is expected to report for quarter end 2023-09-30 ARHT Media Inc. (ART:CA) is expected to report for Q3 2023 Arianne Phosphate Inc. (DAN:CA) is expected to report for quarter end 2023-09-30 EQB Inc. (EQB:CA) is expected to report $2.85 for Q3 2...

KNE:CC - Expected Canadian Company Earnings on Thursday, November 23rd, 2023

Green Impact Partners Inc. (GIP:CA) is expected to report $-0.06 for Q3 2023 Valdor Technology International Inc. (VTI:CA) is expected to report for Q1 2024 Lycos Energy Inc. (LCX:CA) is expected to report for Q1 2024 49 North Resources Inc. (FNR:CA) is expected to report for quarter ...

KNE:CC - Expected earnings - Kane Biotech Inc.

Kane Biotech Inc. (KNE:CA) is expected to report for Q3 2023
KNE:CC - Kane Biotech to Release Third Quarter 2023 Financial Results on November 28, 2023 - Conference Call to Follow

WINNIPEG, Manitoba, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove ...

KNE:CC - Kane Biotech Strengthens Board with Biotech Executive

WINNIPEG, Manitoba, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech” or “Kane”) is pleased to announce that John Coleman has been appointed to the Board of Directors of Kane Biotech effective imm...

KNE:CC - Kane Biotech and ProgenaCare Global Launch Newly Rebranded revyve(TM) Antimicrobial Wound Gel at Advanced Wound Care Fall Forum

WINNIPEG, Manitoba, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech”) in partnership with ProgenaCare Global LLP (“ProgenaCare”) today announces the launch of the newly rebranded revyve™ A...
KNE:CC - Kane Biotech to Exhibit at Symposium on Advanced Wound Care Fall Forum

WINNIPEG, Manitoba, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announces that it will be unveiling the new brand for its coactiv+™ Antimicrobial Wound Gel product (“Wound Gel”...

KNE:CC - Kane Biotech Announces Closing of Fully Subscribed Private Placement Offering and Amendments to its Credit Facility

Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “ Company ”, “ Kane ” or “ Kane Biotech ”) announ...

KNE:CC - Kane Biotech: Top 10 Undervalued Biotechnology Industry Stocks (KNE)

2023-09-02 20:00:00 ET Kane Biotech is now ranked among the top 10 undervalued stocks in the Biotechnology industry on the Toronto Stock Exchange or TSX Venture Exchange. A stock is considered undervalued if it trades at a discount to its valuation – a calculation used to det...
Previous 10 Next 10